Sarepta Therapeutics Overview
Sarepta Therapeutics Target Price
Analysts' 12-month price predictions for SRPT.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.96
Average Target Price
$23.00
28.1% upside
28.1% upside5 analysts in the last 4 months
High: $35 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-09 | Piper Sandler | $20 | 11.4% upside |  |
| 2026-07-08 | Wolfe Research | $27 | 50.3% upside | |
| 2026-05-15 | Evercore ISI | $19 | 5.8% upside | |
| 2026-03-26 | Deutsche Bank | $14 |  22% downside | |
| 2026-03-26 | Wedbush | $35 | 94.9% upside | |
| 2026-03-12 | Mizuho SecuritiesUy Ear | $31 | 72.6% upside | |
| 2026-03-03 | Loop Capital MarketsIlya Zubkov | $25 | 39.2% upside | |
| 2026-03-03 | JefferiesAndrew Tsai | $30 | 67% upside | |
| 2026-01-27 | Robert W. Baird | $22 | 22.5% upside | |
| 2025-12-09 | Wedbush | $32 | 78.2% upside | |
| 2025-11-25 | Bernstein | $20 | 11.4% upside | |
| 2025-11-05 | Barclays | $20 | 11.4% upside | |
| 2025-11-05 | Mizuho SecuritiesUy Ear | $26 | 44.8% upside | |
| 2025-11-04 | Robert W. BairdBrian Skorney | $15 | 16.5% downside | |
| 2025-10-30 | Piper SandlerBiren Amin | $16 | 10.9% downside | |
| 2025-09-09 | Leerink PartnersJoseph Schwartz | $15 | 16.5% downside | |
| 2025-08-21 | Barclays | $22 | 22.5% upside | |
| 2025-08-15 | Deutsche BankDavid Hoang | $12 | 33.2% downside | |
| 2025-07-22 | BarclaysGena Wang | $18 | 0.2% upside | |
| 2025-07-21 | BMO CapitalKostas Biliouris | $50 | 178.4% upside | |
| 2025-07-19 | Leerink PartnersJoseph Schwartz | $10 | 44.3% downside | |
| 2025-06-25 | H.C. Wainwright | $10 | 44.3% downside | |
| 2025-06-17 | Wells FargoYanan Zhu | $75 | 317.6% upside | |
| 2025-06-16 | Cantor FitzgeraldKristen Kluska | $20 | 11.4% upside | |
| 2025-06-15 | BMO CapitalKostas Biliouris | $70 | 289.8% upside | |
| 2025-04-21 | Piper Sandler | $110 | 512.5% upside | |
| 2024-11-27 | Piper SandlerBiren Amin | $182 | 913.4% upside | |
| 2024-11-27 | NeedhamGil Blum | $202 | 1024.7% upside | |
| 2024-11-07 | Robert W. BairdBrian Skorney | $193 | 974.6% upside | |
| 2024-11-07 | Cantor FitzgeraldKristen Kluska | $167 | 829.8% upside | |
| 2024-10-21 | JefferiesAndrew Tsai | $165 | 818.7% upside | |
| 2024-08-08 | Evercore ISIGavin Clark-Gartner | $179 | 896.7% upside | |
| 2024-08-08 | Piper SandlerBiren Amin | $200 | 1013.6% upside | |
| 2024-08-08 | BarclaysGena Wang | $203 | 1030.3% upside | |
| 2024-08-08 | RBC CapitalBrian Abrahams | $181 | 907.8% upside | |
| 2024-07-29 | RBC CapitalBrian Abrahams | $182 | 913.4% upside | |
| 2024-06-27 | BMO CapitalKostas Biliouris | $200 | 1013.6% upside | |
| 2024-06-26 | Piper SandlerBiren Amin | $205 | 1041.4% upside | |
| 2024-06-24 | Evercore ISIGavin Clark-Gartner | $185 | 930.1% upside | |
| 2024-06-24 | Mizuho SecuritiesUy Ear | $200 | 1013.6% upside | |
| 2024-06-21 | Robert W. BairdBrian Skorney | $200 | 1013.6% upside | |
| 2024-06-13 | Robert W. BairdBrian Skorney | $170 | 846.5% upside | |
| 2024-06-13 | Piper SandlerBiren Amin | $157 | 774.2% upside | |
| 2024-06-13 | BarclaysGena Wang | $185 | 930.1% upside | |
| 2024-06-07 | BMO CapitalKostas Biliouris | $170 | 846.5% upside | |
| 2024-05-28 | RBC CapitalBrian Abrahams | $142 | 690.6% upside | |
| 2024-05-20 | RBC CapitalBrian Abrahams | $157 | 774.2% upside | |
| 2024-05-17 | Mizuho SecuritiesUy Ear | $179 | 896.7% upside | |
| 2024-05-14 | OppenheimerHartaj Singh | $180 | 902.2% upside | |
| 2024-05-06 | Morgan StanleyMatthew Harrison | $165 | 818.7% upside | |